What are the signs of peripheral arterial disease (PAD) in a 40‑year‑old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Signs of PAD in a 40-Year-Old Woman

A 40-year-old woman with PAD is unlikely to present with classic intermittent claudication and should be evaluated for atypical leg symptoms, rest pain, diminished or absent lower extremity pulses, femoral bruits, and nonhealing wounds, with confirmation by ankle-brachial index (ABI) testing.

Risk Assessment in This Age Group

While PAD is more common in older adults, a 40-year-old woman falls into the at-risk category if she has:

  • Diabetes mellitus plus one additional atherosclerotic risk factor (smoking, hypertension, hyperlipidemia, family history of PAD) 1
  • Known atherosclerotic disease in another vascular bed (coronary, carotid, renal arteries) 1
  • Age 50-64 years with risk factors (though she's slightly younger, aggressive risk factors warrant evaluation) 1

Clinical Presentation: Sex-Specific Differences

Women with PAD present differently than men, which is critical for diagnosis in this demographic:

Symptom Patterns

  • Only 25.9% of women present with classic intermittent claudication (vs. 30.2% in men) 2
  • Rest pain is MORE common in women (12.8% vs. 9.2% in men, OR 1.40) 2
  • Atypical leg symptoms are MORE prevalent in women (22.8% vs. 19.8% in men) 2
  • Many women are asymptomatic or have nonspecific symptoms 3, 4

Classic Claudication Features (when present)

  1. Muscle pain (cramping) in calf, buttock, thigh, or foot 5
  2. Pain develops only with exercise 5
  3. Pain resolves within 10 minutes of rest 5
  4. Reproducible at similar walking distances 5

Atypical Presentations (more common in this patient)

  • Pain beginning at rest but worsening with exertion 1
  • Pain not stopping the patient from walking 1
  • Pain beginning with exertion but not relieving within 10 minutes 1
  • Nonspecific back, buttocks, or leg discomfort 5

Physical Examination Findings

Key signs to assess systematically:

Pulse Examination (Critical)

  • Palpate and grade all pulses: femoral, popliteal, dorsalis pedis, posterior tibial 1
  • Grading system: 0 (absent), 1 (diminished), 2 (normal), 3 (bounding) 1
  • Absent posterior tibial pulse is more accurate than absent dorsalis pedis (dorsalis pedis can be congenitally absent) 1
  • Multiple pulse abnormalities increase likelihood of PAD 1

Auscultation

  • Femoral bruits suggest arterial stenosis 1
  • Abdominal/flank bruits (assess for aortoiliac disease) 6

Inspection of Legs and Feet

  • Nonhealing wounds or ulcerations (may indicate chronic limb-threatening ischemia) 1
  • Gangrene 1
  • Elevation pallor/dependent rubor 1
  • Distal hair loss 6
  • Trophic skin changes 6
  • Hypertrophic nails 6

Blood Pressure

  • Measure in both arms to detect subclavian stenosis (>15-20 mmHg difference is abnormal) 1

Important Caveats

Unreliable signs (do NOT use for diagnosis):

  • Cool or discolored skin 1
  • Delayed capillary refill 1

Common pitfall: Normal pulse examination and absence of bruits significantly decrease PAD likelihood but do not rule it out 1. The majority of PAD patients do not have typical claudication 1.

Diagnostic Confirmation

Physical findings MUST be confirmed with objective testing 1:

Ankle-Brachial Index (ABI)

  • First-line diagnostic test 1, 5
  • ABI ≤0.90 = PAD diagnosis 1
  • ABI 0.91-0.99 = borderline (consider exercise ABI if clinical suspicion high) 1
  • ABI >1.40 = noncompressible (consider toe-brachial index in diabetics) 1

Functional Impact in Women

Women with PAD experience:

  • Decreased exercise capacity 3
  • Reduced quality of life 3
  • Increased risk of depression 3
  • Greater functional impairment even without classic claudication 1

Clinical Algorithm

  1. Screen if: diabetes + 1 risk factor, known atherosclerotic disease elsewhere, or multiple risk factors 1
  2. Ask about: exertional leg symptoms (any type), rest pain, walking impairment, nonhealing wounds 1
  3. Examine: all lower extremity pulses, auscultate femoral arteries, inspect feet/legs with shoes and socks removed 1
  4. Confirm with ABI if any abnormal findings or symptoms 1
  5. Remember: absence of classic claudication does NOT exclude PAD in women 2, 3

References

Research

Differences in Symptom Presentation in Women and Men with Confirmed Lower Limb Peripheral Artery Disease: A Systematic Review and Meta-Analysis.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2022

Research

PAD in women: the ischemic continuum.

Current atherosclerosis reports, 2015

Related Questions

How can peripheral arterial disease (PAD) be distinguished from chronic venous insufficiency (venous stasis) and deep vein thrombosis (DVT) in a patient presenting with leg symptoms?
In peripheral arterial disease (PAD) versus chronic venous stasis, which condition is characterized by shiny skin and a non‑healing ulcer?
In a patient with lower extremity arterial Doppler showing hemodynamically significant stenosis, what is the appropriate management?
What recommendations should I give patients with peripheral artery disease to prevent and manage fungal infections of the big toe?
In a patient with severe peripheral vascular disease and lipodermatosclerosis who is followed by a vascular surgeon but continues to have leg discomfort, does zinc oxide wrapping provide benefit, what other treatment options are appropriate, and should a referral to dermatology be considered?
How many vaccinated individuals develop severe orchitis after receiving two doses of the measles‑mumps‑rubella (MMR) vaccine?
What are aminoglycosides, and what are their contraindications and side effects?
Is it safe for a patient taking a URO supplement to continue using it while on escitalopram (Lexapro), buspirone (Buspar), propranolol, and mixed‑amphetamine (Adderall)?
In a patient with heart failure with reduced ejection fraction on lisinopril 10 mg daily, torsemide 10 mg daily, and dapagliflozin (Jardiance) 25 mg daily who has hyperkalemia and low serum bicarbonate, should the torsemide dose be increased to 20 mg daily and labs be rechecked in 1–2 weeks?
What are the definition, pathogenesis, etiology, clinical features, investigations, and management of sphenoid sinusitis?
What is the optimal blood pressure management strategy for a lupus patient who is currently taking amlodipine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.